Lundbeck Stock OTC Markets
Stocks
HLUKF
DK0061804697
Pharmaceuticals
OTC Markets Traded| Market Cap | 41.98B 6.42B 5.62B 5.18B 4.8B 9.11B 609B 9.26B 62.07B 24.14B 301B 24.1B 23.58B 1,039B | P/E 2026 * |
9.62x | P/E 2027 * | 9.44x |
|---|---|---|---|---|---|
| Enterprise Value | 46.07B 7.04B 6.16B 5.68B 5.27B 10B 669B 10.16B 68.12B 26.49B 330B 26.45B 25.87B 1,140B | EV / Sales 2026 * |
1.79x | EV / Sales 2027 * | 1.62x |
| Free-Float |
30.76% | Yield 2026 * |
3.43% | Yield 2027 * | 3.55% |
Last Transcript: Lundbeck
| 1 day | +6.88% |
| Manager | Title | Age | Since |
|---|---|---|---|
Charl van Zyl
CEO | Chief Executive Officer | 59 | 2023-09-30 |
Jörg Hornstein
DFI | Director of Finance/CFO | 49 | 2022-08-31 |
Johan Luthman
CTO | Chief Tech/Sci/R&D Officer | 67 | 2019-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 2015-03-24 | |
Dorothea Wenzel
CHM | Chairman | 57 | 2025-03-25 |
| Director/Board Member | 67 | 2015-03-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.88% | +5.10% | - | - | 6.32B | |
| +2.95% | +6.85% | +9.79% | +94.63% | 91.82B | |
| +0.92% | +0.91% | +43.00% | +155.09% | 55.63B | |
| -1.24% | +1.27% | -7.78% | +239.63% | 22.51B | |
| -1.76% | +1.76% | -9.87% | -23.67% | 8.16B | |
| -3.98% | +1.78% | -28.31% | -32.96% | 7.86B | |
| -1.28% | +5.32% | -8.10% | -27.73% | 6.86B | |
| +0.76% | +2.79% | -2.53% | +23.61% | 5.31B | |
| -1.98% | +3.77% | -4.81% | -7.46% | 3.71B | |
| +0.59% | +4.41% | +18.35% | +18.48% | 3.41B | |
| Average | +0.19% | +2.41% | +1.08% | +48.85% | 22.81B | |
| Weighted average by Cap. | +1.33% | +2.85% | +13.59% | +108.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.74B 3.94B 3.44B 3.17B 2.94B 5.58B 373B 5.67B 38.06B 14.8B 184B 14.77B 14.45B 637B | 25.82B 3.95B 3.45B 3.18B 2.95B 5.6B 375B 5.69B 38.18B 14.85B 185B 14.82B 14.5B 639B |
| Net income | 4.56B 697M 610M 562M 521M 989M 66.15B 1B 6.74B 2.62B 32.65B 2.62B 2.56B 113B | 4.62B 706M 618M 569M 528M 1B 67.01B 1.02B 6.83B 2.66B 33.07B 2.65B 2.59B 114B |
| Net Debt | 4.09B 625M 547M 504M 467M 887M 59.34B 902M 6.05B 2.35B 29.29B 2.35B 2.3B 101B | -93.58M -14.31M -12.52M -11.54M -10.7M -20.3M -1.36B -20.63M -138M -53.81M -670M -53.72M -52.55M -2.32B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
